Transient Lower Esophageal Sphincter Relaxations and High Resolution Manometry

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Unknown status
CT.gov ID
NCT00931593
Collaborator
(none)
24
3
1
7
8
1.1

Study Details

Study Description

Brief Summary

Transient lower esophageal sphincter relaxations (tLESr) are the main mechanism of gastro-oesophageal reflux disease. They occur without any deglutition in patients but also in healthy volunteers. They are induced by meal.

The gold standard to detect tLESr is esophageal manometry using perfused Dentsleeve probe.

Esophageal high resolution manometry with solid state sensors was developed in the 90s. The examination is easier and more accurate than perfused manometry. The aim of this study is to validate in healthy volunteers the use of high resolution manometry (Sierra Scientific Instruments, California CA) to detect tLESr.

Condition or Disease Intervention/Treatment Phase
  • Device: Esophageal high resolution manometry associated or not with manometry with perfused Dentsleeve probe (as determined by randomization)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Transient Lower Esophageal Sphincter Relaxations Detection Using High Resolution Manometry. Validation in Healthy Volunteers.
Study Start Date :
May 1, 2009
Anticipated Primary Completion Date :
Dec 1, 2009
Anticipated Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: volunteers

This is a descriptive study to compare two techniques (manometry with perfused dentsleeve probe vs high resolution manometry for the identification of tLESr). Each subject is his own control. The date of perfused manometry is randomized to avoid bias due to examinations' order.

Device: Esophageal high resolution manometry associated or not with manometry with perfused Dentsleeve probe (as determined by randomization)
Visit V0 (day 0 - 2 to 14 days): Subject selection Obtaining of written informed consent Visit V1 (day 0): Fasting subject Randomization to determine the examination order Esophageal high resolution manometry (Sierra Scientific Instruments, California CA) associated or not with manometry with perfused Dentsleeve probe (as determined by randomisation): 3-hour recording (1 hour fasting, ingestion of a 600-kcal liquid meal in 10 minutes, 2 hours post prandial) Visit V2 (day 0 + 1 day): Phone contact Visit V3 (day 0 + 2 to 7 days): Same as V1 Visit V4 (V3 + 1 day): Phone contact and end of the study

Outcome Measures

Primary Outcome Measures

  1. The primary outcome is to demonstrate that high resolution manometry allows the detection of meal-induced tLESr. All recordings will be analyzed at the end of each examination and reviewed at the end of the enrolment. []

Secondary Outcome Measures

  1. To compare the number of tLESr detected by high resolution manometry and those detected by manometry with perfused dentsleeve probe. []

  2. To define the characteristics (duration, relaxation amplitude) of high resolution manometry-detected tLESr. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Male or Female between 18 and 60 years

  2. Subject without typical or atypical symptoms of gastro-esophageal reflux disease (heartburn, regurgitation, epigastric pain, chest pain, chronic cough, pharyngeal pain)

  3. Subject without any medication (except oral contraception)

  4. Subject without previous digestive surgery history (except appendicectomy)

  5. Capability to pass manometric probes through each nostril

  6. Subject with health insurance

  7. Written informed consent

  8. No participation to another study at the same time

Exclusion Criteria:
  1. Age under 18 years or upper 60

  2. Pregnant woman or lactation

  3. Incapability to give consent

  4. No written informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital St André, CHU BORDEAUX Bordeaux France 33075
2 Hôpital Edouard Herriot - Hospices Civils de Lyon Lyon France 69437
3 Hôpital Hôtel Dieu, CHU NANTES Nantes France 44093

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: ROMAN Sabine, MD, Hospices Civils de Lyon
  • Principal Investigator: MION François, MD, Hospices Civils de Lyon
  • Principal Investigator: BRULEY DES VARANNES Stanislas, MD, CHRU NANTES
  • Principal Investigator: ZERBIB Frank, MD, CHRU BORDEAUX

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00931593
Other Study ID Numbers:
  • 2008.546/47
First Posted:
Jul 2, 2009
Last Update Posted:
Jul 2, 2009
Last Verified:
Jul 1, 2009

Study Results

No Results Posted as of Jul 2, 2009